4Nishinura M,Yam amoto H,Kita H,et al.Gastro in test inal stromaltum or in the jejunum:diagnosis and contral of bleeding with electrocoagu lation by using doubieballoon enteroscopy[J].J Gastro enterol,2004,39(10):1001-1004.
5Levy AD,Remotti HE,Thompson WM,et al.Gastrointestinal stromal tumors:radioiogic Features with Pathological Correlation[J].Radio Graphics,2003,23(2):283-304.
6Stroob ants S,Goem inn e,J Seegers M,et al.18FDG-Positron en ision tomography for the early for the early predioction of response in adran ced soft tissie sarcon a treated with in atinibmesy lat(G lirec)[J].Eur J Cancer,2003,39(14):2012.
1Brimming P, Andersson J, Meis-Kindblom JM, et al. Neoadjuvant, adjuvant and palliative therapy of gastrointestinal stromal tumours (GIST) with imatinib: a centrebased study of 17 patients[J]. BrJ Cancer, 2003, 89(3): 460-464.
2McAuliffe JC, Hunt KK, Lazar AJ, et al. A randomized phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis[J]. Ann Surg Oncol, 2009, 16(4): 910- 919.
3Blanke CD, Demetri GD, yon Mehren M, et al. Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT [J]. J Clin Oncol, 2008, 26(4): 620-625.
4Demetri GD, yon Mehren M, Blanke CD, et aL Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J]. N Engl J Med, 2002, 347(7): 472-480.
